Psychosis in Parkinson Disease

A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.

slideshow image

For some patients with PD, the neuropsychiatric complications are great.

Related Videos
Related Content

Electroacupuncture Provides Additive Benefits for Motor Function and Bowel Movements in Parkinson Disease

February 7th 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

National Women Physicians Day: 10 Moments That Matter in Medicine

February 3rd 2023

Episode 78: A Virtual Reality Platform for Parkinson Disease

December 2nd 2022

Early Intervention of Deep Brain Stimulation Results in Improvements in Motor, Non-Motor Symptoms of Parkinson Disease

February 3rd 2023

Novartis Discontinues Huntington Disease Program Following Phase 2b Study

February 1st 2023

Electroacupuncture Provides Additive Benefits for Motor Function and Bowel Movements in Parkinson Disease

February 7th 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

National Women Physicians Day: 10 Moments That Matter in Medicine

February 3rd 2023

Episode 78: A Virtual Reality Platform for Parkinson Disease

December 2nd 2022

Early Intervention of Deep Brain Stimulation Results in Improvements in Motor, Non-Motor Symptoms of Parkinson Disease

February 3rd 2023

Novartis Discontinues Huntington Disease Program Following Phase 2b Study

February 1st 2023

Electroacupuncture Provides Additive Benefits for Motor Function and Bowel Movements in Parkinson Disease

February 7th 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

National Women Physicians Day: 10 Moments That Matter in Medicine

February 3rd 2023

Episode 78: A Virtual Reality Platform for Parkinson Disease

December 2nd 2022

Early Intervention of Deep Brain Stimulation Results in Improvements in Motor, Non-Motor Symptoms of Parkinson Disease

February 3rd 2023

Novartis Discontinues Huntington Disease Program Following Phase 2b Study

February 1st 2023
About Us
Advisory Board
Editorial
Contact Us
Advertise
Contact MJH LS
Do Not Sell My Information
Terms and Conditions
Privacy
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.